Prevalence of BRAF V600E mutation in metastatic melanoma of Mexican Mestizo population

被引：0
|
作者：
Ruiz-Garcia, E. [1 ]
Meneses, A. [1 ]
Martinez-Said, H. [1 ]
Aguilar-Ponce, J. L. [1 ]
Mohar, A. [1 ]
Lopez, A. [1 ]
Alonso-Luna, O. [1 ]
Guadarrama-Orozco, J. A. [1 ]
Green, D. [2 ]
Astudillo-de la Vega, H. [3 ]
机构：
[1] Natl Canc Inst, Mexico City, DF, Mexico
[2] Med Sur, Med Oncol, Mexico City, DF, Mexico
[3] Ctr Med Nacl Siglo XXI IMSS, Traslat Canc Res Unit, Mexico City, DF, Mexico
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3760
引用
收藏
页码：S875 / S875
页数：1
相关论文
共 50 条
  • [21] Molecular Platforms Utilized to Detect BRAF V600E Mutation in Melanoma
    Curry, Jonathan L.
    Torres-Cabala, Carlos A.
    Tetzlaff, Michael T.
    Bowman, Christopher
    Prieto, Victor G.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2012, 31 (04) : 267 - 273
  • [22] A new mouse model of BRaf(V600E)-induced metastatic melanoma
    McMahon, Martin
    Dankort, David
    Filenova, Elena
    Curley, David
    Bosenberg, Marcus
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 249 - 249
  • [23] Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation
    Zaina T. Al-Salama
    Drugs, 2021, 81 : 849 - 856
  • [24] Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation
    Al-Salama, Zaina T.
    DRUGS, 2021, 81 (07) : 849 - 856
  • [25] BRAF V600E MUTATION IN A PATIENT WITH METASTATIC ANAPLASTIC GLIONEURAL TUMOR
    Sharma, Archana
    Glod, John
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S95 - S95
  • [26] Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma
    Ponti, Giovanni
    Tomasi, Aldo
    Pellacani, Giovanni
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
  • [27] Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma
    Giovanni Ponti
    Aldo Tomasi
    Giovanni Pellacani
    Journal of Hematology & Oncology, 5
  • [28] PREVALENCE AND CLINICAL SIGNIFICANCE OF BRAF V600E MUTATION IN MULTIPLE MYELOMA
    Rustad, E.
    Dai, H.
    Wader, K.
    Misund, K.
    Hov, H.
    Sundan, A.
    Aarset, H.
    Waage, A.
    HAEMATOLOGICA, 2013, 98 : 327 - 328
  • [29] Clinical and prognostic significance of BRAF V600E mutation in non-metastatic cutaneous melanoma patients
    Tas, F.
    Erturk, K.
    NEOPLASMA, 2019, 66 (04) : 631 - 636
  • [30] The Prognostic Implication of BRAF V600E Mutation in Patients with Stage IIIb In-Transit Metastatic Melanoma
    Read, R.
    Rawson, R.
    Madore, J.
    Lo, S.
    Scolyer, R.
    Thompson, J.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S136 - S136
12345